Clinical Trial Update: Colchicine for Secondary Prevention After Ischemic Stroke (CHANCE-3 EX) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (CHANCE-3 EX) is evaluating colchicine for secondary prevention after ischemic stroke and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Stroke | Phase 3 | Status: NOT_YET_RECRUITING